Blog

More setbacks for Biogen: state’s largest hospital system spurns Alzheimer’s drug

biogen-02900xx5497-3666-0-206

The state’s largest health care provider has declined to administer Biogen Inc.’s new Alzheimer’s drug, citing concerns over its safety and efficacy months after a controversial FDA approval.

Read More